1.27 N/A 0.58% 0.00% Distribution costs (41.75 ) (24.14 ) (17.61 ) 72.95% (19.11%) (13.74%) Administrative expenses (95.74 ) (94.34 ) (1.40 ) 1.48% (43.82%) (53.71%) Other Expenses Impairment loss of
-27.5% -24.5% 2,120.4 1,782.4 -15.9% Other income 31.8 15.9 22.9 -28.1% +44.1% 51.7 38.7 -25.1% Selling and distribution expenses 587.2 536.7 463.7 -21.0% -13.6% 1,175.1 1,000.4 -14.9% Administrative
) % Revenue from sales and service 1,788.5 2,025.3 1,187.1 (236.8) (11.7) 601.4 50.7 Cost of sales and service 1,499.5 1,686.8 998.7 (187.3) (11.1) 500.8 50.1 Selling and distribution expenses 73.7 78.7 52.0
sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the
0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83
trustee, under Clause 20; (13) the trust’s disclosure of information, under Clause 21; (14) the distribution to the unit holders, under Clause 22; (15) the proposal for resolution and the general meeting of
.) Evaluation by GROW Estimation Co.,Ltd. Date 21 June 2012. GROW Estimation Co., Ltd. on the List Valuation Company and Principal Valuers Approved by the Office of the SEC. Total assets value 149,300,000 Baht
1790,1807,1810,1814,1815 total of 5 plots of land total area of 26-2-20 rai in the process of withdrawing the mortgage Evaluation by GROW Estimation Co.,Ltd. Date 21 June 2012. GROW Estimation Co., Ltd. on the List
262-1-71 rai (Less is devoted to the public interest, the remaining area of 0-2-50 rai valuation of 261-3-21 rai or 104,721 square meters, was not indivisible unit.) Evaluation by GROW Estimation Co